HIV/AIDS Therapy
Studies from San Raffaele Scientific Institute, Department of Infectious Diseases reveal new findings on HIV/AIDS therapy
Published in AIDS Weekly, April 19th, 2010
Fresh data on HIV/AIDS are presented in the report 'Raltegravir, maraviroc, etravirine: an effective protease inhibitor and nucleoside reverse transcriptase inhibitor-sparing regimen for salvage therapy in HIV-infected patients with triple-class experience.' According to recent research from Italy, "We prospectively evaluated 28 triple-class experienced HIV-1-infected patients harbouring R5 virus, who received maraviroc, raltegravir and etravirine. By on-treatment analysis, 26 (92%) had less than 50 copies HIV-RNA/ml at week 48."
"The median (interquartile range) 48-week increase in CD4 cell counts was 267 (136-355) cells/microl. Three serious adverse events occurred:...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
Source: AIDS Weekly (2010-04-19)
More Articles from AIDS Weekly
- Duke University Medical Center
Scientists identify how a novel class of antibodies inhibits HIV infection - Elsevier Health Sciences
New investigation supports correlation between XMRV and prostate cancer - Antiretrovirals
Researchers from University of California publish new studies and findings in the area of antiretrovirals - Cancer Gene Therapy
Research from National Cancer Institute provide new insights into cancer gene therapy - Disease Progression
Studies from University of Glasgow add new findings in the area of disease progression - Hepatitis B Virus
Researchers from University of Pittsburgh report on findings in hepatitis B virus - More from this issue of AIDS Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
